We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
Cap. Flow
-$8.74B
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$352M
2
MRK icon
Merck
MRK
+$333M
3
NVDA icon
NVIDIA
NVDA
+$306M
4
TEAM icon
Atlassian
TEAM
+$280M
5
CTVA icon
Corteva
CTVA
+$253M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14.16%
3 Financials 12.95%
4 Consumer Discretionary 9.76%
5 Industrials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTU icon
876
Peabody Energy
BTU
$2.9B
$25.2M 0.01%
953,816
-4,022
-0.4% -$111K
EWC icon
877
iShares MSCI Canada ETF
EWC
$6.33B
$25.2M 0.01%
769,389
-529,900
-41% -$17.6M
BSY icon
878
Bentley Systems
BSY
$10.6B
$25.1M 0.01%
680,144
+238,806
+54% +$8.66M
EMN icon
879
Eastman Chemical
EMN
$8.42B
$25.1M 0.01%
308,280
+29,543
+11% +$2.38M
PK icon
880
Park Hotels & Resorts
PK
$2.97B
$25.1M 0.01%
2,125,029
-1,046,573
-33% -$12.8M
SXT icon
881
Sensient Technologies
SXT
$5.53B
$25M 0.01%
342,343
-28,725
-8% -$2.06M
SFM icon
882
Sprouts Farmers Market
SFM
$8.01B
$24.9M 0.01%
769,053
-47,792
-6% -$1.49M
CHGG icon
883
Chegg
CHGG
$102M
$24.9M 0.01%
983,825
+599,568
+156% +$15.2M
U icon
884
Unity
U
$18.9B
$24.9M 0.01%
869,224
+303,704
+54% +$9.51M
EPAC icon
885
Enerpac Tool Group
EPAC
$1.93B
$24.8M 0.01%
973,917
+793,665
+440% +$19.1M
HI
886
DELISTED
Hillenbrand
HI
$24.8M 0.01%
580,875
-14,858
-2% -$658K
SCCO icon
887
Southern Copper
SCCO
$166B
$24.8M 0.01%
431,161
-23,655
-5% -$1.21M
MMS icon
888
Maximus
MMS
$3.1B
$24.8M 0.01%
337,814
+153,673
+83% +$9.92M
LBRT icon
889
Liberty Energy
LBRT
$3.25B
$24.7M 0.01%
1,544,234
-171,143
-10% -$2.72M
ZION icon
890
Zions Bancorporation
ZION
$10.3B
$24.7M 0.01%
501,584
-48,947
-9% -$2.45M
INSP icon
891
Inspire Medical Systems
INSP
$1.74B
$24.7M 0.01%
97,886
-10,969
-10% -$2.34M
MDRX
892
DELISTED
Veradigm Inc. Common Stock
MDRX
$24.6M 0.01%
1,396,060
+60,964
+5% +$1.02M
PNW icon
893
Pinnacle West Capital
PNW
$12.2B
$24.6M 0.01%
323,199
-1,868
-0.6% -$133K
SBRA icon
894
Sabra Healthcare REIT
SBRA
$5.37B
$24.6M 0.01%
1,977,223
+735,469
+59% +$9.38M
BIPC icon
895
Brookfield Infrastructure
BIPC
$4.85B
$24.4M 0.01%
627,800
+35,477
+6% +$1.51M
TNET icon
896
TriNet
TNET
$3.14B
$24.4M 0.01%
359,998
+69,166
+24% +$4.77M
CNOB icon
897
Center Bancorp
CNOB
$1.78B
$24.4M 0.01%
1,008,045
-24,967
-2% -$614K
BWA icon
898
BorgWarner
BWA
$13.9B
$24.2M 0.01%
684,175
+7,235
+1% +$246K
NLY icon
899
Annaly Capital Management
NLY
$17.4B
$24.2M 0.01%
1,149,874
-2,490
-0.2% -$49K
TNDM icon
900
Tandem Diabetes Care
TNDM
$1.56B
$24.1M 0.01%
536,972
+59,318
+12% +$2.69M

Similar funds

Nuveen's Q4 2022 Portfolio in Review

As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nuveen opened a new position in Atlassian worth $226M.

  • Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
  • Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
  • Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
  • Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
  • Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
  • Nuveen opened 40 new positions and closed 159 in Q4 2022.
  • Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.